COVID-19 may have wreaked havoc on the U.S. economy last year, but it did not derail biotech employment. If anything, the pandemic is expected to stoke increasing numbers of jobs during this decade.
In assessing the impact of COVID-19 on the life sciences late last year, the world’s largest commercial real estate services and investment firm CBRE Group cited U.S. Bureau of Labor Statistics figures in its U.S. Life Sciences Report 2020 to show that the nation’s life sciences workforce dipped in June 2020 to 1.8 million jobs, just 1.3% below its March 2020 peak, and still 1% higher than a year earlier.
